Body Fat Distribution Affects Risk of Prostate Cancer

There is "strong evidence" as classified by the World Cancer Research Fund that obesity is associated with an increased risk of prostate cancer. In order to investigate this further, researchers objectively measured body fat distribution of men and their risk of developing prostate cancer. For this study, called the Age, Gene/Environment Susceptibility-Reykjavik study, results of which were published in Cancer , 1,832 men went through baseline computed tomography (CT) imaging of fat deposition, ...
Continue reading

EN2 Secretions: Potential New Prostate Cancer Target

Researchers discovered that the transcription factor protein Engrailed-2 (EN2), which forms boundaries and guides neurons in development, also plays a role in cancer: tumors secrete EN2, which is then taken up by the surrounding normal cells, preventing immune invasion. Lead researcher Richard Morgan, PhD, Professor of Molecular Oncology at the University of Bradford, remarked, "For tumors to survive, grow bigger, and spread, they need to control the behavior of cancer cells and the normal cells...
Continue reading

New Potential Biomarker Discovered for Treatment of Deadly Prostate Cancer

After a successful initial response to prostate cancer treatment targeting the androgen receptor, some patients develop neuroendocrine prostate cancer (NEPC), which is the deadliest subtype of castration-resistant prostate cancer and does not have an effective treatment. In a new study, researchers from the Sanford Burnham Prebys Medical Discovery Institute (SBP) found that protein kinase C lambda/iota (PKCλ/ι) causes metabolic reprogramming that creates favorable conditions for NEPC to grow. Th...
Continue reading

New Technology Effectively Predicts Prostate Cancer

The most accurate prostate progression prediction technology to date has been developed by researchers from the Icahn School of Medicine at Mount Sinai and the Keck School of Medicine at the University of Southern California. Existing methods of prostate cancer detection include multiparametric magnetic resonance imaging (MRI) and the Prostate Imaging Reporting and Data System Version 2, a five-point scoring scale that categorizes tumors found on the multiparametric MRI. Because they are subject...
Continue reading

New Biomarkers Offer Treatment Clues for Prostate Cancer

Most often, men diagnosed with prostate cancer have a low risk of progression (LRP). However, some men have intermediate or high risk of progression (IHRP). Physicians tend to overtreat or undertreat patients because they do not have a reliable way to accurately determine the risk of progression. A new study published in Mayo Clinic Proceedings has provided a potential solution to this dilemma. "We have discovered new molecular markers that can help guide men in their decisions about the course ...
Continue reading

© Copyright 2019 i3 Health. All rights reserved.